Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Jun 2026 for Pacira BioSciences, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Christopher Christie: trading record in brief
Christopher Christie is a declared insider of Pacira BioSciences, Inc. (board member), with filings sourced from SEC (Form 4). We count 7 filings; the first trade dates from 9 June 2020 and the latest from 10 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 12 June 2026, reports a share grant in Pacira BioSciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher Christie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
6,405 sharesCommon StockSEC:0001628280-26-043008:0
6,163 shares0Common StockSEC:0001396814-25-000082:0
5,230 shares0Common StockSEC:0001396814-24-000083:0
1,775 shares0Common StockSEC:0001209191-23-038018:0
1,160 shares0Common StockSEC:0001209191-22-035216:0
1,066 shares0Common StockSEC:0001209191-21-040080:0
6 of 6 declarations
